New drug could be gamechanger for those with Alzheimer’s … but you can’t get it in Canada – CTV
September 30, 2025
Two drugs that have shown success in slowing the progression of Alzheimer’s disease are not available in Canada, which is now the only country in the G7 that has not authorized its use.
It’s leading to growing frustration for patients and care partners who are eager for new treatments.
“I think I either have to wait or go to the (United) States,” said Morley, who was diagnosed with mild Alzheimer’s disease three years ago. “That’s the dilemma we are in.”
Morley learned he had Alzheimer’s accidentally. He got a concussion after a fall while skiing and his wife encouraged him to see a specialist to make sure everything was OK. A PET scan revealed amyloids in his brain, a protein associated with Alzheimer’s, which were unrelated to his concussion.
“It was serendipitous that they took a PET scan,” he said. “I don’t think I would have found out otherwise.”
As with every disease, early detection and treatment is key. Morley has quit drinking, exercises regularly, eats well and tries to get as much sleep as possible.
“I’ve been diagnosed with a mild cognitive impairment, and I’d like to keep it like that, rather than get worse,” he said.
